Iron alters Ca2+ homeostasis in doxorubicin-resistant K562 cells

被引:2
|
作者
Yalcintepe, Leman [1 ]
Erdag, Demet [1 ]
Akbas, Fahri [2 ]
Kucukkaya, Bahire [3 ]
机构
[1] Istanbul Univ, Istanbul Fac Med, Dept Biophys, Istanbul, Turkey
[2] Bezmialem Vakif Univ, Fac Med, Dept Med Biol, Istanbul, Turkey
[3] Istanbul Yeni Yuzyil Univ, Fac Med, Dept Biophys, Istanbul, Turkey
关键词
doxorubicin; drug resistance; intracellular calcium; iron; INOSITOL 1,4,5-TRISPHOSPHATE RECEPTOR; MULTIDRUG-RESISTANCE; INTRACELLULAR CALCIUM; MOLECULAR-MECHANISMS; NA+/CA2+ EXCHANGERS; THERAPY RESISTANCE; P-GLYCOPROTEIN; CANCER; SENSITIVITY; METABOLISM;
D O I
10.1111/1440-1681.13295
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Iron is an essential trace element especially in cell proliferation, and growth for various cellular events. An increasing amount of research has shown that iron metabolism is altered in tumour cells which usually have rapid growth rates. However, the number of studies on iron metabolism, and calcium regulation are limited in drug-resistant tumour cells. Previously, we have shown that modulation of iron metabolism through iron chelation regulated the intracellular calcium, and increased the doxorubicin sensitivity. In the present study, we investigated the effects of iron on mRNA expression profiles of fifteen key genes (IP(3)R1/2/3, RYR1/2, SERCA1/2/3, NCX1/2/3, PMCA1/2/3, and PMCA4) related to calcium homeostasis in the parental cell line K562 and its subclone doxorubicin-resistant K562 cells. According to the Delta Delta Ct method with a two-fold expression difference (P < .05) as a cut-off level, although iron showed differential effects on most of the genes, IP3R and PMCA genes were especially determined to have changed significantly. These results show that iron metabolism is an important metabolism due to changes in the expression of genes involved in calcium regulation and is a new perspective to overcome cancer/drug resistance.
引用
收藏
页码:1221 / 1230
页数:10
相关论文
共 50 条
  • [1] Mitochondrial localization and activity of P-glycoprotein in doxorubicin-resistant K562 cells
    Munteanu, E
    Verdier, M
    Grandjean-Forestier, F
    Stenger, C
    Jayat-Vignoles, C
    Huet, S
    Robert, J
    Ratinaud, MH
    BIOCHEMICAL PHARMACOLOGY, 2006, 71 (08) : 1162 - 1174
  • [2] Lntracellular Ca2+ regulates the cellular iron uptake in K562 cells
    Ci, WM
    Li, WY
    Ke, Y
    Qian, ZM
    Shen, X
    CELL CALCIUM, 2003, 33 (04) : 257 - 266
  • [3] Alterations in the expression of cytochrome c oxidase subunits in doxorubicin-resistant leukemia K562 cells
    Grandjean, F
    Brémaud, L
    Robert, J
    Ratinaud, MH
    BIOCHEMICAL PHARMACOLOGY, 2002, 63 (05) : 823 - 831
  • [4] Monitoring the expression profiles of doxorubicin-resistant K562 human leukemia cells by serial analysis of gene expression
    Yoshikazu Ichikawa
    Makoto Hirokawa
    Namiko Aiba
    Naohito Fujishima
    Atsushi omatsuda
    Hirobumi Saitoh
    Masaaki Kume
    Ikuo Miura
    Ken-ichi Sawada
    International Journal of Hematology, 2004, 79 : 276 - 282
  • [5] Monitoring the expression profiles of doxorubicin-resistant K562 human leukemia cells by serial analysis of gene expression
    Ichikawa, Y
    Hirokawa, M
    Aiba, N
    Fujishima, N
    Komatsuda, A
    Saitoh, H
    Kume, M
    Miura, I
    Sawada, K
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2004, 79 (03) : 276 - 282
  • [6] Diosgenin induces cell cycle arrest and apoptosis in human leukemia K562 cells with the disruption of Ca2+ homeostasis
    Liu, MJ
    Wang, Z
    Ju, Y
    Wong, RNS
    Wu, QY
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2005, 55 (01) : 79 - 90
  • [7] Diosgenin induces cell cycle arrest and apoptosis in human leukemia K562 cells with the disruption of Ca2+ homeostasis
    Ming-Jie Liu
    Zhao Wang
    Yong Ju
    Ricky Ngok-Shun Wong
    Qing-Yu Wu
    Cancer Chemotherapy and Pharmacology, 2005, 55 : 79 - 90
  • [8] Dual PI3K/mTOR inhibitor NVP-BEZ235 decreases the proliferation of doxorubicin-resistant K562 cells
    Li, Jie
    Wang, Xiaozi
    Ma, Chuanbao
    Xu, Shasha
    Xu, Mengyao
    Yang, Jie
    Wang, Ruicang
    Xue, Liying
    MOLECULAR MEDICINE REPORTS, 2021, 23 (04)
  • [9] Proanthocyanidin from grape seeds enhances doxorubicin-induced antitumor effect and reverses drug resistance in doxorubicin-resistant K562/DOX cells
    Zhang, XY
    Li, WG
    Wu, YJ
    Bai, DC
    Liu, NF
    CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY, 2005, 83 (03) : 309 - 318
  • [10] Troglitazone overcomes doxorubicin-resistance in resistant K562 leukemia cells
    Davies, GF
    Roesler, WJ
    Juurlink, BHJ
    Harkness, TAA
    LEUKEMIA & LYMPHOMA, 2005, 46 (08) : 1199 - 1206